Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-056593
Filing Date
2018-10-30
Accepted
2018-10-30 19:24:44
Documents
2
Period of Report
2018-10-30

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 6336
2 POA DOCUMENT poa.txt EX-24.3_815130 3862
  Complete submission text file 0001209191-18-056593.txt   11633
Mailing Address 455 MISSION BAY BOULEVARD SOUTH, SUITE 5 SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH, SUITE 5 SAN FRANCISCO CA 94158 408-410-0105
Twist Bioscience Corp (Issuer) CIK: 0001581280 (see all company filings)

EIN.: 462058888 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O TWIST BIOSCIENCE CORPORATION 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address
Finn Patrick John (Reporting) CIK: 0001755970 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38720 | Film No.: 181148271